| Literature DB >> 27852477 |
Ala Al-Lawati1, Anson Cheung2.
Abstract
Mitral valve disease prevalence is on the rise worldwide, affecting an estimated 2% of the general population. Novel transcatheter mitral valve replacement technologies are being developed and may provide a viable and safe option in patients who are deemed otherwise not suitable candidates for conventional mitral valve surgery. This article reviews these devices and describes trials of first in-human use.Entities:
Keywords: Catheter-based therapy; Mitral regurgitation; Mitral valve devices; Transcatheter mitral valve replacement
Mesh:
Year: 2015 PMID: 27852477 DOI: 10.1016/j.iccl.2015.08.010
Source DB: PubMed Journal: Interv Cardiol Clin ISSN: 2211-7458